Elisa Oltra
Elisa Oltra, aka Elisa Oltra Garcia, PhD., is a professor of Cell and Molecular Biology at the Universidad Católica de Valencia "San Vicente Mártir", Valencia, Spain. Her areas of research include stem cell, cancer, fibromyalgia and genetics.[1][2]
2017 Ramsay Award[edit | edit source]
A team comprised of Dr. Elisa Oltra of Universidad Católica de Valencia, Spain, and Drs. Lubov Nathanson, Vladimir Beljanski and Malav Suchin Trivedi of Nova Southeastern University, US, were awarded a 2017 Ramsay Award grant from the Solve ME/CFS Initiative for researching the effect of ME/CFS on epigenetic regulation in specific immune cell types.[3]
Committees and working groups[edit | edit source]
ME/CFS Common Data Element (CDE) Project[edit | edit source]
Chair of the Biomarkers Working Group and a member of the Baseline/Covariate Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control & Prevention.[4]
EUROMENE[edit | edit source]
Participating member of the Biomarkers Working Group of EUROMENE, a European Union, COST Action CA15111, not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[5]
Notable studies[edit | edit source]
- 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE[6] - (Full Text)
- 2018, Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns[7] - (Full Text)
- 2018, Unraveling the Molecular Determinants of Manual Therapy: An Approach to Integrative Therapeutics for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[8] - (Full text)
- 2018, Culturing Adult Stem Cells for Cell-Based Therapeutics: Neuroimmune Applications[9] - (Full text)
- 2019, Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking back on Treatments[10] - (Abstract)
- 2019, Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation[11] - (Full text)
Talks and interviews[edit | edit source]
- 2016, Speaker at the 11th Invest in ME International ME Conference on "Molecular Biomarkers of Myalgic Encephalomyelitis"[12] - DVD available
- 2018, UK CFS/ME Research Collaborative Conference - MRC Funded Update: Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of Chronic Fatigue Syndrome
See also[edit | edit source]
References[edit | edit source]
- ↑ https://www.researchgate.net/profile/Elisa_Oltra
- ↑ "Elisa Oltra García: "Trabajamos en el desarrollo de un test válido y objetivo para el diagnóstico de la fibromialgia"". www.oei.es. Retrieved May 2, 2019.
- ↑ "2017 Ramsay Award Program Results". Solve ME/CFS Initiative. Retrieved May 2, 2019.
- ↑ "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019. Cite has empty unknown parameter:
|dead-url=
(help) - ↑ "Action CA15111". COST. Retrieved July 16, 2019.
- ↑ Scheibenbogen, Carmen; Freitag, Helma; Blanco, Julià; Capelli, Enrica; Lacerda, Eliana; Authier, Jerome; Meeus, Mira; Castro Marrero, Jesus; Nora-Krukle, Zaiga; Oltra, Elisa; Strand, Elin Bolle; Shikova, Evelina; Sekulic, Slobodan; Murovska, Modra (July 26, 2017). "The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE". Journal of Translational Medicine. 15 (1). doi:10.1186/s12967-017-1263-z. ISSN 1479-5876. PMC 5530475. PMID 28747192.
- ↑ Trivedi, Malav S.; Oltra, Elisa; Sarria, Leonor; Rose, Natasha; Beljanski, Vladimir; Fletcher, Mary Ann; Klimas, Nancy G.; Nathanson, Lubov (July 2018). "Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns". PlosOne. doi:10.1371/journal.pone.0201066.
- ↑ Espejo, José; García-Escudero, María; Oltra, Elisa (September 9, 2018). "Unraveling the Molecular Determinants of Manual Therapy: An Approach to Integrative Therapeutics for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". International Journal of Molecular Sciences. 19 (9): 2673. doi:10.3390/ijms19092673.
- ↑ Moreno-Manzano, Victoria; Oltra Garcia, Elisa (November 5, 2018). "Culturing adult stem cells for cell-based therapeutics: Neuroimmune Applications" (PDF). Retrieved November 16, 2018. Cite has empty unknown parameter:
|dead-url=
(help) - ↑ Eloy Almenar-Pérez,; Sánchez-Fito, Teresa; Ovejero, Tamara; Nathanson, Lubov; Oltra, Elisa (February 14, 2019). "Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking back on Treatments". Preprints (2019020134). doi:10.20944/preprints201902.0134.v1.CS1 maint: extra punctuation (link)
- ↑ Almenar-Pérez, Eloy; Ovejero, Tamara; Sánchez-Fito, Teresa; Espejo, José A.; Nathanson, Lubov; Oltra, Elisa (April 2019). "Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation". Clinical Therapeutics. 41 (4): 675–698. doi:10.1016/j.clinthera.2019.02.012.
- ↑ "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.